This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: United Biomedical, Inc.. Active years: 2011-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2012
Title: The Innovative Contributions of Kenneth K Sokoll in Immunogen Delivery Systems
Introduction
Kenneth K Sokoll, an inventive mind based in Stony Brook, NY, has made significant strides in the field of immunology through his patented innovations. With two registered patents to his name, Sokoll is dedicated to enhancing immune response mechanisms, crucial for the advancement of medical treatments and vaccines.
Latest Patents
Sokoll's most notable invention is the "Stabilized Synthetic Immunogen Delivery System.” This patent describes an immunostimulatory complex designed to function as both an adjuvant and a stabilizer for peptide immunogens. The complex incorporates a CpG oligonucleotide alongside a biologically active peptide immunogen. This particular formulation is designed to efficiently present peptide immunogens to immune system cells, thereby prompting a robust immune response. The patent also highlights potential applications for parenteral administration, including a suspension formulation and variations such as w/o-emulsions or in-situ gelling polymers. These innovations aim to enhance the delivery of immunogens, providing a protective immune response in subjects.
Career Highlights
Sokoll is currently affiliated with United Biomedical, Inc., where he plays a crucial role in advancing immunological research and product development. His work focuses on creating more effective methods for delivering immunogens, showcasing a commitment to improving public health through scientific innovation.
Collaborations
Throughout his career, Sokoll has engaged in collaborations with numerous research institutions and companies dedicated to the field of biotechnology and immunology. These partnerships have facilitated the exchange of ideas and resources, allowing for the continued development of groundbreaking immunogen delivery systems.
Conclusion
Kenneth K Sokoll stands out as a significant inventor in the medical field, with a focus on immunogen delivery systems that could revolutionize vaccine efficacy and disease prevention strategies. His contributions underscore the importance of innovation in addressing health challenges and advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
